TriNutra's ThymoQuin Black Seed Oil Softgels Receive Eurofins NSF/ANSI 173 Certification

TriNutra’s ThymoQuin black seed oil softgel capsules have received Eurofins NSF/ANSI 173 Dietary Supplement Product Certification, extending the same certification to its ThymoQuin Premium and ThymoQuin Premium Organic lines.¹

The certification, issued by Eurofins Assurance, confirms the products met the requirements of the NSF/ANSI 173-2024a standard following an independent review of manufacturing controls, labeling accuracy, and product quality.

"Establishing safety, quality, and purity has always been the foundation of everything we do at TriNutra," noted Morris Zelkha, CEO of TriNutra. "Our investment in clinical research is only meaningful if every batch of ThymoQuin consistently reflects the same level of quality and standardization. Achieving Eurofins Certification provides independent verification of that commitment and offers our partners additional confidence in the products they bring to market."

For finished-product manufacturers, third-party certification against NSF/ANSI 173 carries specific weight because it is an American National Standard developed specifically for testing and certifying dietary supplements, rather than a general food-safety or manufacturing designation.² That distinction matters in a raw material category, botanical oils, where identity verification and contaminant screening have historically been inconsistent across suppliers.

What Does NSF/ANSI 173 Certification Actually Verify?

The certification process for ThymoQuin included verification of ingredient identity, label compliance, a facility review, analytical testing, contaminant screening, and microbiological testing. NSF/ANSI 173 certification is designed to function as a communication tool between ingredient and finished-product manufacturers, retailers, and healthcare practitioners, confirming that a supplement's contents match its label and that it does not contain specific undeclared contaminants.³

Because validated laboratory methods do not yet exist for every botanical constituent, the standard is periodically updated as new testing methods become available, which is part of why TriNutra's certification is specifically tied to the current 2024a revision.³

What Clinical and Regulatory Standing Does ThymoQuin Currently Hold?

Separate from this certification, ThymoQuin holds self-affirmed generally recognized as safe status in the United States and is approved for use in foods and dietary supplements by regulatory bodies including the European Food Safety Authority, Australia's Therapeutic Goods Administration, the Thai Food and Drug Administration, and Health Canada, according to the company. Nigella sativa, the botanical source of black seed oil, has an extensive traditional-use history, and thymoquinone, its primary bioactive constituent, has been studied for anti-inflammatory and antioxidant activity across a range of preclinical and clinical research.

One published randomized, placebo-controlled trial using ThymoQuin specifically examined effects on upper-respiratory complaints and mood state in endurance runners, part of the broader gut-stress axis research the company references in its current positioning.⁴ It’s also important to note that the study was funded by TriNutra and conducted by a research firm whose principals disclosed financial ties to the supplement industry, including one author's employment at a company that sells a product containing black cumin seed oil.⁴

How Should This Certification Be Weighed Against the Underlying Science?

Product certification and clinical substantiation answer different questions, and it is worth keeping that distinction clear. NSF/ANSI 173 certification verifies that a finished product's contents match its label and meet quality and manufacturing benchmarks; it does not itself validate specific health claims or clinical outcomes associated with an ingredient.

The clinical research behind thymoquinone and black seed oil, including work specific to ThymoQuin, is a separate evidence stream, and manufacturers evaluating the ingredient should weigh certification and clinical data independently, taking sponsorship and study design into account, rather than treating one as confirmation of the other.

References

1. TriNutra's ThymoQuin achieves Eurofins NSF/ANSI 173 dietary supplement product certification [press release]. TriNutra; August 19, 2026. Press release provided via email.

2. NSF. Product and ingredient certification. Accessed August 19, 2026. https://www.nsf.org/nutrition-wellness/product-and-ingredient-certification

3. Schirn A. NSF/ANSI 173:2024 — dietary supplements. American National Standards Institute July 26, 2024. Accessed August 19, 2026. https://blog.ansi.org/ansi/nsf-ansi-173-2024-dietary-supplements/

4. Talbott SM, Talbott JA. Effect of ThymoQuin black cumin seed oil as a natural immune modulator of upper-respiratory tract complaints and psychological mood state. Food Sci Nutr Res. 2022;5(1):1-6. doi:10.33425/2641-4295.1057